Skin Treatments
Latisse
We conducted a clinical trial on LATISSEâ„¢ (bimatoprost ophthalmic solution) 0.03%, documenting progress throughout key points in the 16-week treatment period. The following case studies feature photographs of real women with real results. Their eyelashes have not been retouched.
In the clinical study, 78% had a significant increase in overall eyelash prominence (including elements of length, fullness, and darkness) at week 16.
